Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic value of response after upfront therapy for acute GVHD
    Journal Article

    Saliba, R. M.; Couriel, D. R.; Giralt, S.; Rondon, G.; Okoroji, G. J.; Rashid, A.; Champlin, R. E.; Alousi, A. M.
    Bone Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
    Journal Article

    Bashir, Q.; Shah, N.; Parmar, S.; Wei, W.; Rondon, G.; Weber, D. M.; Wang, M.; Orlowski, R. Z.; Thomas, S. K.; Shah, J.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Analysis of outcomes in patients (pts) with relapsed/refractory acute promyelocytic leukemia (APL) treated with and without high-dose chemotherapy and hematopoietic stem cell transplantation (HCT)
    Meeting Abstract

    Pemmaraju, N.; Ravandi, F.; Rondon, G.; Giralt, S.; Chen, J.; Pierce, S.; Champlin, R. E.; De Lima, M.; Qazilbash, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • High-dose therapy and posttransplantation symptom burden: Striking a balance
    Book Section

    Giralt, S. A.; Williams, L. A.
    In Cleeland, C. S.; Fisch, M. J.; Dunn, A. J. (Eds.) Cancer Symptom Science: Measurement, Mechanics, and Management (2011)

    Fulltext@MSK | Save
  • Patterns of disease relapse and progression in patients with multiple myeloma after first line therapy with autologous stem cell transplantation: Implications for patient monitoring after transplantation
    Meeting Abstract

    Zamarin, D.; Bhutani, M.; Chimento, D.; Giralt, S.; Lendvai, N.; Landau, H.; Lesokhin, A.; Chung, D.; Babu, D.; Hassoun, H.
    Blood (2011)

    Fulltext@MSK | Save
  • Safety and immunogenicity of the 13-valent protein-conjugated pneumococcal vaccine(PCV13) following related and unrelated hematopoietic stem cell transplantation (HCT)
    Meeting Abstract

    Small, T. N.; Jakubowski, A. A.; Barker, J. N.; Kernan, N. A.; Prockop, S. E.; Iovino, C. S.; Lestrange, N.; Perales, M. A.; Castro-Malaspina, H.; Koehne, G.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Non-myeloablative allogeneic hematopoietic stem cell transplantation with low-dose total body irradiation and peri-transplant rituximab for B cell non-Hodgkin lymphoma: Favorable disease control in chemosensitive patients
    Meeting Abstract

    Sauter, C. S.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; Lechner, L.; Moskowitz, C. H.; Giralt, S.; Barker, J. N.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell (HSC) boosts from the original donor without conditioning for poor graft function (PGF) following allogeneic hematopoietic stem cell transplants (HSCT)
    Meeting Abstract

    Rosenzweig, M. A.; Kernan, N. A.; Small, T. N.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; Boulad, F.; Giralt, S.; Young, J. W.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • A randomized phase II trial of fludarabine/melphalan 140 vs fludarabine/melphalan 100 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
    Meeting Abstract

    Qazilbash, M.; Thall, P. F.; Liu, P.; Orlowski, R. Z.; Bashir, Q.; Shah, N.; Kebriaei, P.; Parmar, S.; Jones, R.; Hosing, C. M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Graft-versus-host disease (GVHD) after double-unit cord blood transplantation (DCBT) is associated with unique clinical features including a higher incidence of grade III-IV acute GVHD in children
    Meeting Abstract

    Ponce, D. M.; Gonzales, A. M.; Lubin, M. N.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; van den Brink, M. R. M.; more...
    Blood (2011)

    Fulltext@MSK | Save